Notal Vision Monitoring Center Reports AI Analysis of 10 Million ForeseeHome AMD Home Monitoring Tests

Manassas, Virginia (November 30, 2021) - The Notal Vision Monitoring Center celebrates the artificial intelligence (Al) based analysis of the ten millionth test performed by over 20,000 patients with the FDA-cleared ForeseeHome device. The device is part of a comprehensive remote monitoring service for intermediate age-related macular degeneration (AMD) patients at risk of developing the sight threatening wet form of the disease. The service monitors patients between office eye exams, when it`s difficult to manage the acute onset of wet disease that requires timely treatment.

A recent large scale data analysis showed that the use of ForeseeHome provided a significant benefit to patients by helping to detect their wet AMD earlier with better visual acuity,1 a factor previously shown to improve long-term visual outcomes of treatment.2 "The real-word data published earlier this year shows that the performance of the ForeseeHome program resembles the findings from the randomized controlled AREDS2-HOME study,3 which ultimately led to Medicare coverage of the monitoring service we provide," said Kester Nahen, PhD, CEO of Notal Vision.

Patients are referred to the Notal Vision Monitoring Center for the ForeseeHome program by their ophthalmic physician. Once a referral is received, the Monitoring Center manages everything from benefit verification, patient engagement, device provisioning and training to compliance monitoring and alert notification. Patients perform a short, daily test on an easy-to-use device and their results are automatically transmitted to the Monitoring Center. A statistically significant change in testing generates an alert, which is reviewed by in-house ophthalmologists and sent to the referring physician`s office so they can determine the best course of action for their patient. Patient testing data is also available to referring physicians via an online portal, which provides clinically actionable insights that can help inform patient care.

"Patients require ongoing assistance and a positive and empowering experience to be successful across years of home diagnostic testing. Their home monitoring experience reflects positively on physicians and their practice in addition to the medical benefit", said Barbara Benedict, Vice President of Notal Vision Monitoring Center Strategy and Operations. "Directed by practicing ophthalmologists and supported by a team of certified ophthalmic professionals, the Monitoring Center is a Medicare accredited and HIPAA compliant digital healthcare provider and the epicenter of patient and physician engagement that provides a safety net against vision loss between eye exams."